BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9155115)

  • 1. [Significance of transrectal ultrasound and sextant systematic core biopsy for performing radical prostatectomy].
    Fujimoto H; Tobisu K; Niwakawa M; Kume H; Tomita K; Mizutani T; Tsutsumi M; Kakizoe T
    Nihon Hinyokika Gakkai Zasshi; 1997 Apr; 88(4):479-87. PubMed ID: 9155115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site.
    Gregori A; Vieweg J; Dahm P; Paulson DF
    Urol Int; 2001; 66(2):66-71. PubMed ID: 11223746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens.
    Peller PA; Young DC; Marmaduke DP; Marsh WL; Badalament RA
    Cancer; 1995 Jan; 75(2):530-8. PubMed ID: 7529129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens.
    Altay B; Kefi A; Nazli O; Killi R; Semerci B; Akar I
    Urol Int; 2001; 67(1):14-8. PubMed ID: 11464109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy.
    Vis AN; Boerma MO; Ciatto S; Hoedemaeker RF; Schröder FH; van der Kwast TH
    Urology; 2000 Oct; 56(4):617-21. PubMed ID: 11018617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrasound-guided biopsy: screening of prostate cancer with a single set of 14 systematic biopsies].
    Perdonà S; De Sio M; Damiano R; Oliva A; D'Armiento M
    Arch Ital Urol Androl; 2000 Dec; 72(4):258-63. PubMed ID: 11221051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of systematic ultrasound-guided staging biopsies in predicting extraprostatic extension and seminal vesicle invasion in men with prostate cancer.
    Okihara K; Kamoi K; Lane RB; Evans RB; Troncoso P; Babaian RJ
    J Clin Ultrasound; 2002; 30(3):123-31. PubMed ID: 11948567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping.
    Salomon L; Colombel M; Patard JJ; Lefrère-Belda MA; Bellot J; Chopin D; Abbou CC
    Eur Urol; 1999 Apr; 35(4):289-93. PubMed ID: 10087390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
    Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H
    J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
    Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
    Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of prostate cancer missed by sextant biopsy.
    Bak JB; Landas SK; Haas GP
    Clin Prostate Cancer; 2003 Sep; 2(2):115-8. PubMed ID: 15040873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of sextant biopsies to predict radical prostatectomy stage.
    Wills ML; Sauvageot J; Partin AW; Gurganus R; Epstein JI
    Urology; 1998 May; 51(5):759-64. PubMed ID: 9610589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer.
    Epstein JI; Walsh PC; Sauvageot J; Carter HB
    J Urol; 1997 Nov; 158(5):1886-90. PubMed ID: 9334623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy.
    Fink KG; Hutarew G; Esterbauer B; Pytel A; Jungwirth A; Dietze O; Schmeller NT
    Urology; 2003 Apr; 61(4):748-53. PubMed ID: 12670559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of transrectal ultrasonography and core biopsies with pathology results in radical prostatectomy specimens.
    Türkeri L; Tarcan T; Biren T; Küllü S; Akdaş A
    Int J Urol; 1996 Nov; 3(6):459-61. PubMed ID: 9170573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions.
    Loch T; Eppelmann U; Lehmann J; Wullich B; Loch A; Stöckle M
    World J Urol; 2004 Nov; 22(5):357-60. PubMed ID: 15672278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer.
    Taylor JA; Gancarczyk KJ; Fant GV; Mcleod DG
    Urology; 2002 Nov; 60(5):841-5. PubMed ID: 12429312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
    Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
    Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.